MERGER ALERT – IMPV and ATHN: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies

Loading...
Loading...

NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies.

athenahealth, Inc. ATHN
Merger Announcement: November 12, 2018
Transaction Details: athenahealth will be purchased by an affiliate of Veritas Capital and Evergreen Coast Capital. Under the terms of the transaction, athenahealth shareholders will receive $135 per share; the transaction has a total approximate value of $5.7 billion in cash. 

To learn more about the ATHN investigation and your rights, go tohttps://www.zlk.com/mna/athenahealth-inc.

Imperva, Inc. IMPV
Merger Announcement: October 10, 2018
Transaction Details: Imperva, Inc. will be purchased by Thoma Bravo, LLC. Under the terms of the transaction, Imperva shareholders will receive $55.75 per share.

To learn more about the action and your rights, go tohttps://www.zlk.com/mna/imperva-inc.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
jlevi@levikorsinsky.com 
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com 

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...